[1] |
. Wiley Interdiscip Rev Syst Biol Med, 2019, 11(5): e1450.
|
[2] |
Vaudel M, Barsnes H, R?der H, et al. Using proteomics bioinformatics tools and resources in proteogenomic studies[J]. Adv Exp Med Biol, 2016, 926: 65-75.
|
[3] |
Joubert R, Strub JM, Zugmeyer S, et al. Identification by mass spectrometry of two-dimensional gel electrophoresis-separated proteins extracted from lager brewing yeast[J]. Electrophoresis, 2001, 22(14): 2969-2982.
|
[4] |
Chen GD, Pramanik BN. Application of LC/MS to proteomics studies: current status and future prospects[J]. Drug Discov Today, 2009, 14(9/10): 465-471.
|
[5] |
Cs?sz, Deák E, Kalló G, et al. Diabetic retinopathy: proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms[J]. J Proteomics, 2017, 150: 351-358.
|
[6] |
Haythorne E, Rohm M, van de Bunt M, et al. Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells[J]. Nat Commun, 2019, 10(1): 2474.
|
[7] |
Mohan V, Radha V. Precision diabetes is slowly becoming a reality[J]. Med Princ Pract, 2019, 28(1): 1-9.
|
[8] |
Wang Y, An HY, Liu T, et al. Metformin improves mitochondrial respiratory activity through activation of AMPK[J]. Cell Rep, 2019, 29(6): 1511-1523.e5.
|
[9] |
Khan RMM, Chua ZJY, Tan JC, et al. From pre-diabetes to diabetes: diagnosis, treatments and translational research[J]. Medicina (Kaunas), 2019, 55(9): E546.
|
[10] |
Metz TO, Qian WJ, Jacobs JM, et al. Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset[J]. J Proteome Res, 2008, 7(2): 698-707.
|
[11] |
Zhang QB, Fillmore TL, Schepmoes AA, et al. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes[J]. J Exp Med, 2013, 210(1): 191-203.
|
[12] |
Soggiu A, Piras C, Bonizzi L, et al. A discovery-phase urine proteomics investigation in type 1 diabetes[J]. Acta Diabetol, 2012, 49(6): 453-464.
|
[13] |
Huth C, von Toerne C, Schederecker F, et al. Protein markers and risk of type 2 diabetes and prediabetes: a targeted proteomics approach in the Kora F4/FF4 study[J]. Eur J Epidemiol, 2019, 34(4): 409-422.
|
[14] |
Lietzén N, Hirvonen K, Honkimaa A, et al. Coxsackievirus B persistence modifies the proteome and the secretome of pancreatic ductal cells[J]. iScience, 2019, 19: 340-357.
|
[15] |
Lutty GA. Effects of diabetes on the eye[J]. Invest Ophthalmol Vis Sci, 2013, 54(14): ORSF81.
|
[16] |
Rangasamy S, McGuire PG, Das A. Diabetic retinopathy and inflammation: novel therapeutic targets[J]. Middle East Afr J Ophthalmol, 2012, 19(1): 52-59.
|
[17] |
Whitehead M, Osborne A, Widdowson PS, et al. Angiopoietins in diabetic retinopathy: current understanding and therapeutic potential[J]. J Diabetes Res, 2019, 2019: 5140521.
|
[18] |
Jin J, Min H, Kim SJ, et al. Development of diagnostic biomarkers for detecting diabetic retinopathy at early stages using quantitative proteomics[J]. J Diabetes Res, 2016, 2016: 6571976.
|
[19] |
Torok Z, Peto T, Csosz E, et al. Tear fluid proteomics multimarkers for diabetic retinopathy screening[J]. BMC Ophthalmol, 2013, 13(1): 40.
|
[20] |
Hirao Y, Saito S, Fujinaka H, et al. Proteome profiling of diabetic mellitus patient urine for discovery of biomarkers by comprehensive MS-based proteomics[J]. Proteomes, 2018, 6(1): E9.
|
[21] |
Campion CG, Sanchez-Ferras O, Batchu SN. Potential role of serum and urinary biomarkers in diagnosis and prognosis of diabetic nephropathy[J]. Can J Kidney Health Dis, 2017, 4: 2054358117705371.
|
[22] |
Yoon JJ, Park JH, Kim HJ, et al. Dianthus superbus improves glomerular fibrosis and renal dysfunction in diabetic nephropathy model[J]. Nutrients, 2019, 11(3): E553.
|
[23] |
Thippakorn C, Schaduangrat N, Nantasenamat C. Proteomic and bioinformatic discovery of biomarkers for diabetic nephropathy[J]. EXCLI J, 2018, 17: 312-330.
|
[24] |
de Boer IH, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort[J]. Arch Intern Med, 2011, 171(5): 412-420.
|
[25] |
Son MK, Yoo HY, Kwak BO, et al. Regression and progression of microalbuminuria in adolescents with childhood onset diabetes mellitus[J]. Ann Pediatr Endocrinol Metab, 2015, 20(1): 13-20.
|
[26] |
van JA, Scholey JW, Konvalinka A. Insights into diabetic kidney disease using urinary proteomics and bioinformatics[J]. J Am Soc Nephrol, 2017, 28(4): 1050-1061.
|
[27] |
Moresco RN, de Carvalho JAM. Applying proteomics to diagnosis of diabetic kidney disease[J]. Expert Rev Proteomics, 2017, 14(10): 841-843.
|
[28] |
Harpole M, Davis J, Espina V. Current state of the art for enhancing urine biomarker discovery[J]. Expert Rev Proteomics, 2016, 13(6): 609-626.
|
[29] |
Papale M, di Paolo S, Vocino G, et al. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies[J]? J Nephrol, 2014, 27(3): 221-228.
|
[30] |
Wende AR. Post-translational modifications of the cardiac proteome in diabetes and heart failure[J]. Proteomics Clin Appl, 2016, 10(1): 25-38.
|
[31] |
Dewey S, Sohal M, Gomes AV. Proteomic analysis of Akita mice reveals 9 proteins altered during early stages of diabetic cardiomyopathy[J]. Biophys J, 2013, 104(2): 313a-314a.
|
[32] |
Pai YW, Lin CH, Lin SY, et al. Reconfirmation of newly discovered risk factors of diabetic peripheral neuropathy in patients with type 2 diabetes: a case-control study[J]. PLoS One, 2019, 14(7): e0220175.
|
[33] |
Hosseini A, Abdollahi M. Diabetic neuropathy and oxidative stress: therapeutic perspectives[J]. Oxid Med Cell Longev, 2013, 2013: 168039.
|
[34] |
Zhang TJ, Gao YB, Gong YB, et al. Tang-Luo-ning improves mitochondrial antioxidase activity in dorsal root Ganglia of diabetic rats: a proteomics study[J]. Biomed Res Int, 2017, 2017: 8176089.
|
[35] |
Singh A, Subramani E, Datta Ray C, et al. Proteomic-driven biomarker discovery in gestational diabetes mellitus: a review[J]. J Proteomics, 2015, 127(Pt A): 44-49.
|
[36] |
Kim SM, Park JS, Norwitz ER, et al. Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes[J]. Reprod Sci, 2012, 19(2): 202-209.
|
[37] |
Seyhan AA, Carini C. Are innovation and new technologies in precision medicine paving a new era in patients centric care [J]?J Transl Med, 2019, 17(1): 114.
|
[38] |
Vitzthum F, Behrens F, Anderson NL, et al. Proteomics: from basic research to diagnostic application. A review of requirements & needs[J]. J Proteome Res, 2005, 4(4): 1086-1097.
|
[39] |
Colhoun HM, Marcovecchio ML. Biomarkers of diabetic kidney disease[J]. Diabetologia, 2018, 61(5): 996-1011.
|